Health Press Release – Newsletter for March 5, 2011

/C O R R E C T I O N – Bristol-Myers Squibb and AstraZeneca/

PARIS and LONDON, March 4, 2011 – In the news release, "ONGLYZA(R) Becomes the First DPP-4 Inhibitor
Available for Use in Europe" issued on 4 Mar 2011 08:00 GMT, by
Bristol-Myers Squibb and AstraZeneca NYSE:AZN over PR Newswire, we would
like to advise that the headline was incorrectly transmitted by
PR Newswire and should have read "ONGLYZA(R) Becomes … Original article on : /C O R R E C T I O N — Bristol-Myers Squibb and AstraZeneca/.